ESTP Congress 2006: Case No 1


Digital slide(s):	Case 1-1: 3 day control Case 1-2: 3 day high dose Case 1-3: 7 Day high dose Case 1-4: 13 weeks control Case 1-5: 13 weeks high dose
Species / breed:	Mouse/ CD-1 Crl: CD-1 (ICR)BR
Sex:	Male
Age:	6-7 weeks at start of study
Study type:	13-week pre-oncogenicity and 7-day investigative
Treatment:
Clinical findings:	Pale fundus preterminal ophthalmoscopy at 13-week
Organ(s):	Eye
Gross finding(s):
Staining:	H&E